Related Experiment Videos

Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction?

Joseph L Evans1, Ira D Goldfine, Betty A Maddux

  • 1Medical Research Institute, San Francisco, California. University of California at San Francisco, San Francisco, California 94107, USA. jevansphd@earthlink.net

Diabetes
|December 28, 2002
PubMed

Insights

High glucose and fatty acids cause diabetic complications by increasing reactive oxygen species (ROS) and reactive nitrogen species (RNS). These activate stress pathways, leading to organ damage and insulin resistance in diabetes.

Area of Science:

  • Biochemistry
  • Cellular Biology
  • Endocrinology

Background:

  • Chronic hyperglycemia in diabetes mellitus (type 1 and type 2) leads to target organ complications.
  • Elevated glucose and fatty acids contribute to oxidative stress via reactive oxygen species (ROS) and reactive nitrogen species (RNS).

Purpose of the Study:

  • To investigate the role of hyperglycemia- and free fatty acid (FFA)-induced stress pathway activation in diabetic complications.
  • To explore the contribution of these pathways to insulin resistance and impaired insulin secretion in type 2 diabetes.

Main Methods:

  • The study proposes a mechanism involving ROS/RNS generation and activation of stress-sensitive pathways.
  • Key pathways discussed include nuclear factor-kappaB, p38 MAPK, JNK/SAPK, and hexosamine pathways.

Main Results:

  • ROS and RNS directly damage DNA, proteins, and lipids.
  • These reactive species also indirectly induce tissue damage by activating cellular stress pathways.
  • Evidence suggests these pathways contribute to insulin resistance and impaired insulin secretion in type 2 diabetes.

Conclusions:

  • Hyperglycemia-induced activation of stress pathways is crucial for diabetic complications in both type 1 and type 2 diabetes.
  • FFA-induced activation of these pathways may also contribute to diabetic complications.
  • These stress pathways are implicated in both the late-stage complications and metabolic dysfunction (insulin resistance/secretion) of type 2 diabetes.

Related Concept Videos